SECOND LOAN MODIFICATION AGREEMENTLoan Modification Agreement • August 6th, 2010 • Caliper Life Sciences Inc • Laboratory analytical instruments
Contract Type FiledAugust 6th, 2010 Company IndustryThis Second Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of May 24, 2010, by and between (i) SILICON VALLEY BANK, a California corporation, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts 02462 (“Bank”) and (ii) CALIPER LIFE SCIENCES, INC., a Delaware corporation with a principal place of business located at 68 Elm Street, Hopkinton, Massachusetts 01748 (“Caliper”), NOVASCREEN BIOSCIENCES CORPORATION, a Maryland corporation (“NovaScreen”), XENOGEN CORPORATION, a Delaware corporation (“Xenogen”), and CALIPER LIFE SCIENCES LTD., a company organized under the laws of Canada (“Caliper Ltd.”) (hereinafter, Caliper, NovaScreen, Xenogen, and Caliper Ltd. are jointly and severally, individually and collectively, referred to as “Borrower”).
STOCK PURCHASE AGREEMENT TACONIC FARMS, INC., XENOGEN CORPORATION and CALIPER LIFE SCIENCES, INC.Stock Purchase Agreement • August 6th, 2010 • Caliper Life Sciences Inc • Laboratory analytical instruments • New York
Contract Type FiledAugust 6th, 2010 Company Industry JurisdictionPortions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Registrant’s application requesting confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • August 6th, 2010 • Caliper Life Sciences Inc • Laboratory analytical instruments • Massachusetts
Contract Type FiledAugust 6th, 2010 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into this 17th day of May, 2010, by and between Biotage LLC, a Delaware limited liability company (“Buyer”) and Caliper Life Sciences, Inc., a Delaware corporation (“Seller”).